Symptoms

Symptoms

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Two of GRACE's earliest followers, Laya Dogmetchi and Jim Celebucki, talk about how the Global Resource for Advancing Cancer Education helps cancer...
Cancer Journey:
Disease Learning:
During the Targeted Therapies in Lung Cancer Patient Forum, many of our fantastic and loved attendees shared with us what they are grateful for. For our sixth video in this month of gratitude, Ann Broo shared what she is thankful for with GRACE.
Cancer Type:
Disease Learning:
During the Targeted Therapies in Lung Cancer Patient Forum, many of our fantastic and loved attendees shared with us what they are grateful for. For our fifth video in this month of gratitude, Rita Johnson shared her thoughts with GRACE.
Cancer Type:
Disease Learning:
During the Targeted Therapies in Lung Cancer Patient Forum, many of our fantastic and loved attendees shared with us what they are grateful for. In this fourth video we feature our friend Mara Greenberg.
Cancer Type:
Disease Learning:
During the Targeted Therapies in Lung Cancer Patient Forum, many of our fantastic and loved attendees shared with us what they are grateful for. For our third video in this month of gratitude, Don Fredal shared with GRACE.
Cancer Type:
Disease Learning:

Articles

Amidst all of the glowing reports about immunotherapy for lung and many other cancers, it would be understandable for patients and physicians to be tempted to rush toward prioritizing immunotherapy as the first treatment strategy to pursue. In fact ...
Cancer Journey:
Cancer Type:
Probably the most immediate potentially practice-changing presentation from ASCO was the Japanese J-ALEX study in the subset of about 4-5% of...
Cancer Journey:
Cancer Type:
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy options for treatment of both sensitive and refractory small cell lung cancer (SCLC).
Cancer Journey:
Cancer Type:
Janet Daily-Freeman moderates a question & answer session with Drs. Leora Horn and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for ALK+ and ROS1 patients.
Cancer Journey:
Cancer Type:
The brain is a common site of disease in patients with ALK+ lung cancer. In this video, Dr. Horn illustrates the line-up of ALK+ treatments and how they work breaking through the blood/brain barrier.
Cancer Journey:
Cancer Type:

Community Forum

My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
Cancer Type:
It is as if my mom's digestive system is now paralyzed. No one seems to know what to do or how to give her relief from the nausea and discomfort, or...
Cancer Journey:
I’m a 40yr old female with a smoking history of 20+ years. I have chronic brown phlegm (for years) with little to no coughing. I had a chest X-ray in...
Cancer Journey:
Cancer Type:
Disease Learning: